Bicycle Therapeutics (BCYC) Tax Provisions (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Tax Provisions of $172000.0 for Q1 2026, down 91.87% on a QoQ basis from $2.1 million in Q4 2025, and up 115.82% year-over-year from $79694.8 in Q1 2025.
Bicycle Therapeutics (BCYC) Tax Provisions (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Tax Provisions history runs 9 years deep, the most recent figure standing at $172000.0 for Q1 2026.
- Quarterly Tax Provisions rose 115.82% year-over-year to $172000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 141.19% YoY) and the FY2025 annual result came in at $1.0 million, up 120.88% from the prior year.
- Tax Provisions was $172000.0 for Q1 2026 at Bicycle Therapeutics, down from $2.1 million in the prior quarter.
- Across five years, Tax Provisions topped out at $2.3 million in Q3 2023 and bottomed at -$3.4 million in Q3 2024.
- A 5-year average of -$207117.6 and a median of -$396000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions jumped 1250.0% — and 2024, when it tumbled 412.89%.
- Bicycle Therapeutics' Tax Provisions stood at -$396000.0 in 2022, then jumped by 190.15% to $357000.0 in 2023, then tumbled by 412.89% to -$1.1 million in 2024, then surged by 289.35% to $2.1 million in 2025, then tumbled by 91.87% to $172000.0 in 2026.
- Business Quant data shows BCYC's Tax Provisions at $172000.0 in Q1 2026, $2.1 million in Q4 2025, and $200000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | 172,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 172,000.00 |
| Dec 31, 2025 | 2.12 Mn |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | -200,000.00 |
| Mar 31, 2025 | -1.09 Mn |
| Dec 31, 2024 | -1.12 Mn |
| Sep 30, 2024 | -3.45 Mn |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | -400,000.00 |
| Dec 31, 2023 | 357,000.00 |
| Sep 30, 2023 | 2.30 Mn |
| Jun 30, 2023 | -517,000.00 |
| Mar 31, 2023 | -600,000.00 |
| Dec 31, 2022 | -396,000.00 |
| Sep 30, 2022 | -200,000.00 |
| Jun 30, 2022 | -400,000.00 |
| Mar 31, 2022 | -400,000.00 |
| Dec 31, 2021 | -800,000.00 |
| Sep 30, 2021 | -400,000.00 |
| Jun 30, 2021 | -200,000.00 |